The finals of the Tianjin Xiqing District’s Golden Technology Innovation Project Competition was successfully held on the 20th of November 2019. This competition was jointly organized by Tianjin Xiqing District’s Federation of Trade Unions and Tianjin Xiqing District’s Human Resources and Social Security Bureau. It was conceived (1) to encourage innovative and creative thinking by employees from the industries based in the Tianjin Xiqing District and (2) to build a business development platform for bringing together the wisdom, strength and resources from these local industries, in order to promote high-quality business developments in the Tianjin Xiqing District. After nearly three months of hard work and preparation, Beroni China’s submission of the innovation project “Old Drug New Usage for Cancer Treatment” has won a number of awards.
The “Old Drug New Usage for Cancer Treatment” idea is a research project undertaken by team members of Beroni China’s R&D Center for Precision Medicine. Dr. Eric Wang, an associate professor-level researcher for Beroni China’s R&D Center for Precision Medicine, is the leader in charge of this research project. Dr. Zhenghu Jia, the vice president of Beroni China’s R&D Center for Precision Medicine was the project presenter.
The purpose of this research project is not to directly kill the cancer cells in the patient’s body, but to inhibit angiogenesis and limit blood flow to the cancer cells by blocking the renin-angiotension system through commonly used and safe anti-hypertensive drugs AT1R inhibitors (ARBs). Limiting development of peripheral blood vessels and the supply of oxygen and nutrition to cancer cells will inhibit the growth of the cancer cells, reduce the chance of cancer recurrence and improve the patient’s survival rate, whilst not interfering with the general recovery of the patient, including their immune system.
Beroni China has won a total of four awards, through the unremitting efforts of the Beroni China’s R&D team during both the preliminary and final rounds. The project “Old Drug New Usage for Cancer Treatment” won the Second Prize for Innovation award. Beroni China won the award for “Innovation Capability” and also the award for “Special Contribution”. In addition, Dr. Wang won the “Star of Innovation” award.
Through participating in Tianjin Xiqing District’s Golden Technology Innovation Project Competition, Beroni China has learnt and grown in its development of a culture of innovation and creativity. This event not only successfully enhanced the company’s reputation and popularity amongst the large number of enterprises within the Tianjin Xiqing District, but also honed the research and innovation skills of the R&D staff. In addition, it has strengthened the spirit of unity and teamwork of the entire company and also its continuous commitment to achieving greater heights!
